Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
Postovsky
S
S
Beck
D
D
Ben-Izhak
O
O
Arush
M W
MW
D018262:Adenocarcinoma, Clear Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D002291:Carcinoma, Papillary / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000556:secondary / Q000601:surgery; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D015080:Mesna / Q000008:administration & dosage; D016609:Neoplasms, Second Primary / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D013964:Thyroid Neoplasms / Q000601:surgery; D013965:Thyroidectomy; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D015080:Mesna; D002945:Cisplatin; D007069:Ifosfamide